We explore the frontiers of healthcare and biology by unlocking the power of genomics. With a focus on innovation and impact, our research is driving a future where diagnostics are faster, more accurate, and accessible to all, enabling truly personalized care.
We offer rapid and highly accurate NGS-based diagnostic products for infectious diseases. Our solutions support early detection, resistance profiling, and public health surveillance.
Our targeted NGS-based TB test enables ultra-sensitive detection of Mycobacterium tuberculosis and drug-resistance mutations. It supports timely, accurate, and personalised treatment decisions.
Collaborate with usWe offer an advanced NGS assay for detecting and genotyping high risk HPV strains. It provides greater sensitivity than conventional methods and supports early cervical cancer prevention.
Collaborate with usWe have developed innovative NGS-based tools in oncology to enable precision diagnostics and monitor treatment response with high accuracy and low invasiveness.
Our oncology platforms integrate genomic, transcriptomic, and epigenomic signals to detect cancer signatures and guide therapy selection with high precision.
Collaborate with usWe offer a liquid biopsy based approach for monitoring tumor burden, resistance, and recurrence using circulating tumor DNA (ctDNA) all from a simple blood sample.
Collaborate with usThe Onco-Microbiome refers to the complex relationship between the human microbiome (the trillions of microbes living in and on the body) and cancer development, progression, and treatment outcomes.
Collaborate with usTransplant Genomics is the use of advanced genomic technologies to monitor, predict, and improve outcomes after organ or stem cell transplantation. It focuses on identifying genetic and molecular changes that signal how the body is responding to a transplant particularly to detect graft rejection, immune complications, or relapse early and accurately.
Collaborate with usFamilial Hypercholesterolemia (FH) is a genetic disorder that causes very high levels of LDL cholesterol ("bad cholesterol") in the blood from an early age. If left undiagnosed or untreated, it significantly increases the risk of early heart disease, including heart attacks, even in young adults or children.
Collaborate with usRare diseases (also known as orphan diseases) are medical conditions that affect a small percentage of the population, often fewer than 1 in 2,000 people. Though each rare disease is uncommon, there are over 7,000 known rare diseases, collectively affecting millions of people worldwide.
Collaborate with us